# Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

> **NCT06218199** · PHASE4 · RECRUITING · sponsor: **Heart Center Research, LLC** · enrollment: 80 (estimated)

## Conditions studied

- Heart Failure, Congestive

## Interventions

- **DRUG:** Furosemide
- **DRUG:** Torsemide
- **DRUG:** Bumetanide
- **DRUG:** sacubitril/valsartan
- **DRUG:** Hydralazine
- **DRUG:** Isosorbide Dinitrate

## Key facts

- **NCT ID:** NCT06218199
- **Lead sponsor:** Heart Center Research, LLC
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-08
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06218199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06218199, "Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06218199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*